Herrmann Ken (CIK 2049757) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-21). Recent activity: Buy AKTS (3,506 shares), Buy AKTS (1,350 shares), Sell AKTS (3,506 shares), Sell AKTS (1,350 shares), Buy AKTS (3,065 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-21 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 3,506 | $280 |
| 2026-07-21 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 1,350 | $2,578 |
| 2026-07-21 | Aktis Oncology, Inc. (AKTS) | Director | Sell | 3,506 | $86,115 |
| 2026-07-21 | Aktis Oncology, Inc. (AKTS) | Director | Sell | 1,350 | $33,159 |
| 2026-07-20 | Aktis Oncology, Inc. (AKTS) | Director | Buy | 3,065 | $245 |
| 2026-07-20 | Aktis Oncology, Inc. (AKTS) | Director | Sell | 3,065 | $77,259 |
Source: SEC Form 4 filings · as of 2026-07-21